Targeted Delivery Polymeric Nanosystem Reinforced by Synergism of Embilin and RPI-1 for Therapeutics of Pancreatic Cancer-Reference-Cited by-同舟云学术

Targeted Delivery Polymeric Nanosystem Reinforced by Synergism of Embilin and RPI-1 for Therapeutics of Pancreatic Cancer

Published:2022-11-29 Issue:12 Volume:5 Page:18622-18636
ISSN:2574-0970
Container-title:ACS Applied Nano Materials
language:en
Short-container-title:ACS Appl. Nano Mater.

Author:

Arya Jayadev S.¹²^ORCID,Joseph Manu M.¹^ORCID,Murali Vishnu Priya¹^ORCID,Vidyalekshmi Murukan S.¹²^ORCID,Maiti Kaustabh Kumar¹²^ORCID

Affiliation:

1. Chemical Sciences and Technology Division (CSTD), CSIR-National Institute for Interdisciplinary Science and Technology (CSIR-NIIST), Thiruvananthapuram 695019, Kerala, India

2. Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India

Funder

Council of Scientific and Industrial Research

Department of Biotechnology , Ministry of Science and Technology

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsanm.2c04400

Reference43 articles.

1. Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

2. Application of carbon nanotubes in sensing/monitoring of pancreas and liver cancer

3. Cancer statistics, 2018

4. Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

5. c-MET as a potential therapeutic target and biomarker in cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medicinal potential of embelin and its nanoformulations: An update on the molecular mechanism and various applications;IRAN J BASIC MED SCI;2024

2. Synthesis of novel rapanone derivatives via organocatalytic reductive C-alkylation: biological evaluation of antioxidant properties, in vivo zebrafish embryo toxicity, and docking studies;RSC Medicinal Chemistry;2024